Biomarin Pharmaceutical Inc - ESG Rating & Company Profile powered by AI
This page contains a questions and answers section for Biomarin Pharmaceutical Inc. Scroll down to the bottom of the page for potential risks for Biomarin Pharmaceutical Inc based on sector, geography and size. The webpage displays a zero-cost Sustainability report for Biomarin Pharmaceutical Inc.
Biomarin Pharmaceutical Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.6; made up of an environmental score of 4.0, social score of 6.0 and governance score of 6.9.
5.6
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 579 | Tonix Pharmaceuticals Holding Corp | 5.7 | High |
| 579 | VIVA Biotech Holdings | 5.7 | High |
| 602 | Biomarin Pharmaceutical Inc | 5.6 | High |
| 602 | Celltrion Inc | 5.6 | High |
| 602 | Adaptimmune Therapeutics PLC | 5.6 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Biomarin Pharmaceutical Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc report the average age of the workforce?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc offer flexible work?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc conduct supply chain audits?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc disclose water use targets?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Biomarin Pharmaceutical Inc have a product recall in the last two years?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Biomarin Pharmaceutical Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc disclose parental leave metrics?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Biomarin Pharmaceutical Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc disclose its waste policy?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc report according to TCFD requirements?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc disclose energy use targets?
Sign up for free to unlockDoes Biomarin Pharmaceutical Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Biomarin Pharmaceutical Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Biomarin Pharmaceutical Inc
These potential risks are based on the size, segment and geographies of the company.
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. The company's commercial products also comprise Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme, which is delivered through subcutaneous injection to reduce blood Phe concentrations; Brineura, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; Voxzogo, a once daily injection analog of c-type natriuretic peptide for the treatment of achondroplasia; and Aldurazyme, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase. In addition, it develops valoctocogene roxaparvovec, an adeno associated virus vector, which is in Phase III clinical trial for the treatment of patients with severe hemophilia A; BMN 307, an AAV5 mediated gene therapy, which is in Phase 1/2 clinical trial to normalize blood Phe concentration levels in patients with PKU; and BMN 255 that is in Phase 1/2 clinical trial for treating primary hyperoxaluria. The company serves specialty pharmacies, hospitals, and non-U.S. government agencies, as well as distributors and pharmaceutical wholesalers in the United States, Europe, Latin America, and internationally. BioMarin Pharmaceutical Inc. has license and collaboration agreements with Sarepta Therapeutics, Ares Trading S.A., Catalyst Pharmaceutical Partners, Inc., and Asubio Pharma Co., Ltd. The company was incorporated in 1996 and is headquartered in San Rafael, California.